Trials / Conditions / Peripheral Primitive Neuroectodermal Tumor

Peripheral Primitive Neuroectodermal Tumor

5 registered clinical trials studyying Peripheral Primitive Neuroectodermal Tumor — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in P NCT06441331	ITM Solucin GmbH	Phase 1
Recruiting	Liquid Biopsy in Ewing Sarcoma and Osteosarcoma as a Prognostic And Response Diagnostic: LEOPARD NCT06068075	Dana-Farber Cancer Institute	N/A
Completed	Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or H NCT03220035	National Cancer Institute (NCI)	Phase 2
Completed	Vincristine Sulfate, Topotecan Hydrochloride, and Cyclophosphamide With or Without Bevacizumab in Treating You NCT00516295	National Cancer Institute (NCI)	Phase 2
Completed	Trabectedin in Treating Young Patients With Recurrent or Refractory Soft Tissue Sarcoma or Ewing's Family of T NCT00070109	Children's Oncology Group	Phase 2